
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BIO-205
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : MPM Capital
Deal Size : $30.0 million
Deal Type : Series A Financing
MPM backs new biotech in the hunt for non-opioid painkiller
Details : The financing will be used to advance the company’s lead program, BIO-205, through human proof-of-concept studies in neuropathic pain as well as to advance its portfolio of A3AR agonists.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 07, 2020
Lead Product(s) : BIO-205
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : MPM Capital
Deal Size : $30.0 million
Deal Type : Series A Financing
